Close Menu

NEW YORK (360Dx) – Diagnostics firm Quotient said after the close of the market on Tuesday that it has raised $64.6 million in net proceeds from a public offering of its ordinary shares.

The Switzerland-based firm said that it offered 10.6 million shares of its stock at $6.50 per share. The offering's underwriters exercised in full their option to purchase up to almost 1.4 million additional ordinary shares.

Jefferies and Cowen and Company acted as joint book-running managers for the offering.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.